RTW Investments’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $57.8M | Buy |
25,021,584
+6,233,718
| +33% | +$14.4M | 0.82% | 33 |
|
|
2025
Q1 | $26.1M | Buy |
18,787,866
+10,115,236
| +117% | +$14.1M | 0.4% | 38 |
|
|
2024
Q4 | $15M | Sell |
8,672,630
-6,273,790
| -42% | -$10.9M | 0.23% | 49 |
|
|
2024
Q3 | $30M | Sell |
14,946,420
-3,853,879
| -20% | -$7.75M | 0.43% | 40 |
|
|
2024
Q2 | $42.1M | Buy |
18,800,299
+207,114
| +1% | +$464K | 0.65% | 37 |
|
|
2024
Q1 | $53.4M | Buy |
18,593,185
+1,700,000
| +10% | +$4.88M | 0.79% | 38 |
|
|
2023
Q4 | $29.9M | Hold |
16,893,185
| – | – | 0.47% | 36 |
|
|
2023
Q3 | $53.4M | Buy |
+16,893,185
| New | +$53.4M | 1.13% | 23 |
|